SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

FDA has not approved any generic versions of semaglutide." Eli Lilly, makers of Mounjaro and Zepbound, also used for weight loss, told CBS News: "Lilly has taken steps to help inform people about the ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

The FDA has recently updated safety guidelines for certain weight loss medications known as GLP ... include liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy), and tirzepatide ...

Weight loss drugs have exploded into the public spotlight in the U.S., particularly after the FDA approved Wegovy for weight loss in 2021. Wegovy, which is the weight loss version of the drug ...

FDA has not approved any generic versions of semaglutide." Eli Lilly, makers of Mounjaro and Zepbound, also used for weight loss, told CBS News: "Lilly has taken steps to help inform people about ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

an FDA-approved treatment for type 2 diabetes, blew up when people began using it as a weight loss drug. Since then, various medical studies have found that the key ingredient, semaglutide ...